Westchester Medical Center, Valhalla (United States of America)
1
presentation
0
follower
6
more
presentations
in this session
Combining serum miR-144-3p and miR-652-3p as potential biomarkers for the early diagnosis and stratification of acute cellular rejection in heart transplantation patients